These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Charteris DG; Sethi CS; Lewis GP; Fisher SK Eye (Lond); 2002 Jul; 16(4):369-74. PubMed ID: 12101443 [TBL] [Abstract][Full Text] [Related]
16. Retinotomy and silicone oil for detachments complicated by anterior inferior proliferative vitreoretinopathy. Tsui I; Schubert HD Br J Ophthalmol; 2009 Sep; 93(9):1228-33. PubMed ID: 19429589 [TBL] [Abstract][Full Text] [Related]
17. [Retinal shortening: the most severe form of proliferative vitreoretinopathy (PVR)]. Pastor JC; Rodríguez de la Rúa E; Martín F; Mayo-Iscar A; de la Fuente MA; Coco R; Bailez C; Mahave S Arch Soc Esp Oftalmol; 2003 Dec; 78(12):653-7. PubMed ID: 14689321 [TBL] [Abstract][Full Text] [Related]
18. Patomechanisms in proliferative vitreoretinopathy. Kaczmarek R; Misiuk-Hojło M Klin Oczna; 2011; 113(1-3):64-7. PubMed ID: 21853955 [TBL] [Abstract][Full Text] [Related]
19. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin. Kumar A; Tewari HK; Bathwal DP; Khosla PK Indian J Ophthalmol; 1994 Mar; 42(1):31-5. PubMed ID: 7927629 [TBL] [Abstract][Full Text] [Related]
20. Case of rubeosis in association with proliferative vitreoretinopathy (PVR). Bourke RD; Cooling RJ Retina; 1997; 17(3):262-4. PubMed ID: 9196943 [No Abstract] [Full Text] [Related] [Next] [New Search]